comparemela.com

Latest Breaking News On - Douglas miehm - Page 6 : comparemela.com

Bausch + Lomb Corporation (NYSE:BLCO) Q2 2023 Earnings Call Transcript

Bausch + Lomb Corporation (NYSE:BLCO) Q2 2023 Earnings Call Transcript August 2, 2023 Bausch + Lomb Corporation beats earnings expectations. Reported EPS is $0.29, expectations were $0.16. Operator: Greetings. Welcome to the Bausch & Lomb Second Quarter 2023 Earnings Conference Call. [Operator Instructions] I will now turn the conference over to your host, George Gadkowski. […]

China
Canada
United-states
Virginia
America
Sam-eldessouky
Matt-miksic
Bausch-lomb
Brent-saunders
Joanne-wuensch
Douglas-miehm
Patrick-wood

RBC Capital Remains a Hold on Bausch Health Companies (BHC)

RBC Capital analyst Douglas Miehm maintained a Hold rating on Bausch Health Companies (BHC – Research Report) yesterday and set a price ta.

Douglas-miehm
Bausch-health-companie
Oncolytics-biotech
Bausch-health-companies-inc
Bausch-health-companies
Lomb-corporation
Research-report
Health-companies-inc

Monday's analyst upgrades and downgrades - The Globe and Mail

Inside the Market’s roundup of some of today’s key analyst actions

Indiana
United-states
Montreal
Quebec
Canada
Texas
Ireland
Japan
New-york
Algonquin
Illinois
Kinross

Opsens Inc (OPS) Receives a Buy from RBC Capital

Opsens Inc (OPS – Research Report), the Technology company, has received a rating update from a Wall Street analyst on July 13. Analyst Douglas .

Canada
United-states
Japan
Stifel-nicolaus
Douglas-miehm
Lomb-corporation
Aurinia-pharmaceuticals
European-union
Bausch-health-companies
Opsens-inc
Research-report
Wall-street

AUPH Stock Soars As Aurinia Explores 'Strategic Alternatives,' Including A Buyout

AUPH Stock Soars As Aurinia Explores 'Strategic Alternatives,' Including A Buyout
investors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investors.com Daily Mail and Mail on Sunday newspapers.

Bristol-myers-squibb
George-milne
Joseph-hagan
Douglas-miehm
Joseph-schwartz
Schwartz
Aurinia-pharmaceuticals
Wall-street
Sun-pharmaceutical
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.